Get the Stockscreener App
0.61
4.84%
-0.031
After Hours:
.65
0.04
+6.56%
Scorpius Holdings Inc stock is traded at $0.61, with a volume of 112.25K.
It is down -4.84% in the last 24 hours and down -12.54% over the past month.
See More
Previous Close:
$0.641
Open:
$0.6468
24h Volume:
112.25K
Relative Volume:
0.99
Market Cap:
$2.64M
Revenue:
$7.84M
Net Income/Loss:
$-55.03M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-41.00M
1W Performance:
-7.58%
1M Performance:
-12.54%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.60
$0.6687
1-Week Range:
$0.60
$0.68
52-Week Range:
$0.60
$7.2192
Scorpius Holdings Inc Stock (SCPX) Company Profile
Compare SCPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCPX
Scorpius Holdings Inc
|
0.61 | 2.64M | 7.84M | -55.03M | -41.00M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.13 | 120.56B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.22 | 82.44B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.55 | 36.87B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.07 | 32.64B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.39 | 28.38B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scorpius Holdings Inc Stock (SCPX) Latest News
Nvidia earnings more important than CPI, Fed: Barclays - Investing.com
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model - The Manila Times
Scorpius Holdings, Inc. Launches Scorpius Ventures - Marketscreener.com
Scorpius Holdings Inc (SCPX) Quarterly 10-Q Report - Quartzy
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability - The Manila Times
Scorpius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Scorpius Holdings Reports 142% Revenue Growth, Despite $10.1M Q3 Loss | SCPX Stock News - StockTitan
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement - StockTitan
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually - The Manila Times
Scorpius Partners with Biotech Firm to Boost U.S. Biomanufacturing Capabilities - Yahoo Finance
Scorpius Holdings Announces Partnership with U.S. Biotech Company - The Manila Times
Public company puts headquarters up for sublease amid pivot to Texas - The Business Journals
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats - The Manila Times
SCPXScorpius Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities - The Manila Times
Chesterfield accountancy practice acquired by Xeinadin - East Midlands Business Link
Truist Maintains Buy Rating on Crowdstrike with $325 Target - AskTraders
Scotiabank maintains Sector Perform rating on CrowdStrike shares - Investing.com
SMH Capital Advisors Inc. Has $1.58 Million Holdings in Compass Diversified (NYSE:CODI) - Defense World
UBS Group AG Increases Stake in Spirent Communications - TipRanks
UBS Group AG Adjusts Stake in Spirent Communications - TipRanks
Zscaler and CrowdStrike enhance cybersecurity operations - Investing.com
UBS Group AG Ups Stake in Spirent Communications - TipRanks
Glancy Prongay & Murray LLP Reminds Investors of Looming - GlobeNewswire
Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act - U.S. Politics Today
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA - StockTitan
Scorpius Holdings Inc. (SCPX)’s highs and lows: A closer look at its stock price fluctuations - US Post News
It is Poised to be a Bull Market for Scorpius Holdings Inc. (SCPX) - SETE News
Scorpius Holdings revises executive bonus structure - Investing.com
Biotech company Scorpius records threefold rise H1 revenue, secures $14.4M financing - Seeking Alpha
Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced - The Bakersfield Californian
Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow - StockTitan
SCPX Stock Earnings: Scorpius Holdings Reported Results for Q2 2024 - InvestorPlace
Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024 - GlobeNewswire
Scorpius Holdings reports Q2 EPS ($26.98) vs. ($106.67) last year - TipRanks
Scorpius Holdings Announces Successful Public Offering and Strategic Financing Steps - TipRanks
Scorpius Holdings, Inc. Announces Closing of Public Offering - GlobeNewswire
SEC Form 424B4 filed by Scorpius Holdings Inc. - Quantisnow
Scorpius Holdings, Inc. Announces Pricing of Public Offering - GlobeNewswire
Scorpius Holdings, Inc. Announces Pricing of Public Offering | SCPX Stock News - StockTitan
Exclusive: Healthcare Service Provider Scorpius Surpasses $100M In Business Opportunities, Eyes Revenue Boost - AOL
Scorpius Holdings Navigates Offering Hurdles, Eyes Share Sale - TipRanks
Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering - GlobeNewswire
Closing Bell Recap: Scorpius Holdings Inc. (SCPX) Ends at 1.09, Reflecting a -80.64 Downturn - The Dwinnex
SCPX’s price-to-sales ratio: Is it a good investment opportunity? - US Post News
Nasdaq Jumps 250 Points; Disney Earnings Beat EstimatesWalt Disney (NYSE:DIS) - Benzinga
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Scorpio Tankers Inc. (NYSE:STNG) Shares Bought by Vanguard Group Inc. - Defense World
Scorpius Holdings Inc Stock (SCPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Cap:
|
Volume (24h):